Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D2GZ
|
||||
| Former ID |
DIB000481
|
||||
| Drug Name |
AL-408
|
||||
| Synonyms |
AL-108 analog (neurodegenerative diseases), Allon
|
||||
| Indication | Central nervous system disease [ICD10:G00-G99] | Investigative | [531616] | ||
| Company |
Allon Therapeutics Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
N1(C(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H]2N(C(<br />=O)[C@H](NC(=O)[C@@H](CC(=O)N)N)C)CCC2)C(C)C)CO)[C@@H](<br />CC)C)[C@@H](C(=O)N[C@@H](C(=O)O)CCC(=O)N)CCC1
|
||||
| Target and Pathway | |||||
| Target(s) | Microtubule-associated protein tau | Target Info | Modulator | [531616] | |
| KEGG Pathway | MAPK signaling pathway | ||||
| Alzheimer's disease | |||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| Pathway Interaction Database | LPA receptor mediated events | ||||
| Reelin signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.